Forensic Analysis Of Deaths In Pfizer's Early mRNA Vaccine Trial Found Significant Inconsistencies Authored by Megan Redshaw, JD via The Epoch...
Only time and data will tell whether the CDC-recommended reformulated shots can stand their ground against the ever-changing SARS-CoV-2 variants.
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has recently seen a substantial intraday gain of over 15% in its share price. Despite the absence...
An advisory panel told the Food and Drug Administration that the highly sought-after medicines may no longer be suitable for sale.
Amgen and its portfolio of 11 biosimilars is standing behind interchangeability, saying the designation should not be rescinded and that the FDA needs...
BIRMINGHAM, Ala. – In the summer of 2018, graduate student Hunter Dean from the Medical Scientist Training Program came to Yuhua Song, Ph.D., with a...
Researchers still don’t know how well BA.2.86 will evade immunity or whether it will cause more severe disease than its predecessors.
Nicotine e-cigarettes and two prescription medications that curb symptoms of withdrawal are the most effective stop-smoking aids, according to a comprehensive,...
Another biosimilar hopeful for Johnson & Johnson’s Stelara is taking steps to move to market as patent protections are set to end this year, this...
In our latest Trade To Black podcast, we welcome a special guest. TV personality Tim Seymour, host of CNBC’s Fast Money and the CIO of Seymour...
[Singapore — 10:35 a.m. SGT–September 10, 2023] — The oral, selective KRAS G12C inhibitor The oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor...
Megyn Kelly Reveals Possible Vaccine Injury, Regrets Getting COVID Shot Authored by Tom Ozimek via The Epoch Times (emphasis ours), Megyn...
A Deeper Dive Into The Role Of Spike Protein In Myocarditis And Blood Clotting After COVID-19 Vaccination Authored by Allison Kruig, MPH and...
FBI, HHS Stonewalling Congress Over Illegal Chinese COVID Lab In California The Chairman of the House Select Subcommittee on the Coronavirus...
Citius Pharmaceuticals plans to refile its experimental drug for a rare blood cancer in early 2024 following an FDA rejection in July. Leonard Mazur The...
FDA Refuses To Provide COVID-19 Vaccine Safety Data To US Senator Authored by Zachary Stieber via The Epoch Times (emphasis ours), U.S. officials...
CDC Warns RSV Cases Are Rising Among Infants, Babies Authored by Katabella Roberts via The Epoch Times (emphasis ours), The Centers for...
Trump Calls On Big Pharma To Disclose All Vaccine Side Effect Data Authored by Tom Ozimek via The Epoch Times, Former President Donald Trump...
The dangerous health and weight-loss products are being recalled after a hospitalization.
The dangerous health and weight-loss products are being recalled after a hospitalization.
The Drugs Don't Work By Russell Clark of the Capital Flows and Asset Markets substack This week’s Economist has a leader, criticizing America’s...
Despite advances in developing radiopharmaceuticals, manufacturing such drugs remains a challenge. One startup’s plan to tackle the issue is beginning...
With the help of a new grant from the National Institute of Health for more than $2.6 million, Assistant Professor Timothy Huang, Ph.D., will continue...
Penny stocks to buy according to insiders this quarter. The post 3 Top Penny Stocks To Buy Now According To Insiders appeared first on Penny Stocks...
Biocon Biologics is betting big that it can be a top US biosimilars company. With its $3 billion acquisition of Viatris’ biosimilar portfolio last November...
Aktivax Pharma is shutting most operations, closing two out of three facilities and laying off 70 employees due to what the drug auto-injectable manufacturer...
Shankar Ramaswamy’s Kriya Therapeutics has acquired another gene therapy startup for an undisclosed amount. Fatima Bosch Kriya has purchased Tramontane...
As Moderna awaits an FDA decision to kick-start its fall Covid vaccination campaign, the biotech is continuing to beef up its data package. Moderna reported...
Equities continue to shrug off anything the world throws at them as we sit on the precipice of huge technological breakthroughs in energy, biotech, AI,...
All of us want new, improved medicines. Drugs that provide incremental benefits (often called “me too” drugs) are good, but truly revolutionary therapies...